Almonertinib With Bevacizumab for EGFR-Mutant NSCLC Patients With Leptomeningeal Metastasis
Clinical trial NCT04944069 · UNKNOWN
Trial details
- NCT number
- NCT04944069
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-01
- Primary completion
- 2024-03-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.